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Objeclives. This tudy aimed to cempare indium-Ill I”%+ 
meewlce!at adim~asio antibody uptake in patients with dilated 
cardiolnyopatby befm heert haosplaotatte~ with the bistohgic 
tiedings in tbt expt~ted he&s. 
~kgreend. A btgb preveleoce f ‘%t-monoclooel aotimye- 
sin enttbedy up& has bnn oeserthed to patients with dilated 
ardlamyapntbj. ruggcstkg the p-m al e&e, ongoing myo- 
eyte damegee: however, oo correlation brtween mo~~lonet en. 
ttmyopin m(ibed& end btstobgtc findings is availebk in thae 
pettents. 
Melbeds. A ccewcutlve series of 21 patientP sitb &ted 
cwdtemyepathy ewettttg heart trnnsplantatten WPR studied with 
e eedmveein elaGdtt lwfwe the weratten, and the 
mulls were mm&red with lbe Mdegic a&y& of the explanted 
hearts. The inlerwl txlween meeeclonal anttmyyosin aetisody 
studtea eed lr~~pbetettee ws 1 te 90 days (meen 58 + 31). 
Diagnosis of active myocarditis in the clinical context of 
dilated cardiomyopathy is accomplished by endomyocardial 
biopsy. Using uoiform diagnostic hisfopatbolqic critex~a(l). 
the sewitivity of the biopsy has been question.zd because of 
failure to provide a diagnosis in patients with recent onset 
heart failure of unknown origin (2-4). Such failure has been 
ascribed to biopsy sampling error due to the focal nature of 
the disease O-7). Therefore, alternative methods to detect 
active myocarditis have been advocated (6.7). 
Noninvasive identification of one of the compaxnts of 
active myocarditis, myocardial damage. was made possible 
after the introduction of monoclonal antimyosin antiiiies 
by Khaw et al. (&-II) who have shown that these antibodies 
bind specifically IO cardiac myosin when sxcolemmal dis- 
ruption is present attd indicate active myocyte damage. 
These antibwliis have been successfully used to detect active 
of 21 patiwts, but a&c myocarditi n the ex 
oi the myecardium sha 
Conclusions. lo dileted eer=dicea 
ain 3etibGdy uptake eaoaet be qeated w&h the pmsemx ef alI 
intlammatwy mpense detected to the myocardtum of the ee 
myocarditis due !o acute myofardial infarction (8,lO,II) or 
in diffuse myocerdial disease, such as rejection after heart 
transplantation (12-15) or anthracycline therapy (16.17). 
In acute dilated cardiomyopathy W-20) and in chronic, 
stable dilated cardiomyopathy (21). a high prevalence of 
positive results of antimyorin studies indicating active myo- 
cardial damage has been described. In these wies, discrep- 
ancies between positive sciotigraphic findings sod negative 
endomyorardial biopsy findings fw active myocardilis have 
been rcponed. The reasons for such discrepancies are 
unclear. as no reh -n is available that compares antimyosin 
studies with histologic findings in explanted heals of pa- 
tients with dilated cardiomyopathy. 
A prospective study was therefore undertaken in patiees 
with dilated cardiomyopathy comparing results of pretrans- 
plantation monoclonal antimyosin aofibady studies with 
findings in the explanted heart. 
Patients 
Thiny-one patients with the clinical diagsosis of dilated 
cardiomyopathy included in a heart trdnsplaotation program 
were studied with moaoclonal atttimyosin nntibadies before 
the operation. In 10 patients, the interval between antimyo- 
sin administratiat and tmnsplamation was >3 months, and 
they were excluded from analysis, leaving a total of 21 
uaiients. !n onlv 2 of the 21 uatirnts the onset of their hea? 
hisease occ&d <I2 months before operation; therefore, 
this group mainly comprised patients witb cluonic dilated 
cardiomyopathy. 
Methods 
CardiuWmy studies. Hearts excised at transplantation 
were weighed and sectioned in transverse slices 2 cm apart. 
corresponding to basal, midventricular and apical portions of 
both ventricles, and each of them was divided into 9 to 12 
blocks. Rigbt an: left ventricular wall and septal thickness 
were measured. Coronary arteries were dissxted and sec- 
tioned transversely. Blocks were dehydrated and embedded in 
pamtlin, and sections were stained with hematoxytin-wsin and 
examined for areas of cell intiltratian and active ntyocyte 
damage. Histologic diagnosis of mywarditis a1 cxdiiclomy 
was determinated according to the D&u criteria (I). 
lsotoplc prepmallon. RIIDlO-Fab-diethyl:netriamine- 
pen&acetic monoclonal antimyosin antibodies (RIIDIC- 
Fab-DTPA) (Centocor) were labeled with 2 mCi of indium- 
I I I (“‘In)_chloride. Patients received an intradermal 
injection of 0. I ml of the labeled antibody to test for 
hypersensitivity. A dose of 0.5 mg of RIIDlQFab-DTPA 
labeled with 2.0 mCi of “‘In was administered intravenously 
if no adverse reactions to previous tests were observed. No 
adverse reactions were noted in any patient. 
Jmaging. Imaging was undetien at 48 h in the anterior 
projection using a conventional large field-of-view camera 
with a high resolution, medium energy collimator and 20% 
window centered an 24% and 173-k&’ peaks. A minimum of 
SlQOlKl counts was collected between 5 and IO min. Analog 
and digital images collected in a I28 x 128 matrix were 
stored for subsequent analysis. 
loterpantiw of imbpic shdie. Visual inferprefofion. 
And!& of antimyosin uptake was performed by an observer 
una&e of din&l data: In ardeti& project& a four-step 
scorewaF,used:O=nouplalre;I=mildorfaintuptake;Z= 
clear but moderate uptake: 3 = intense myccardiral uptake. 
Heorrllung ratio. To substantiate an index of antimyosin 
uptake, the digital unprocessed anterior projection at 48 h 
was examined. A region of interest was normalized bath to 
the myocardium and to each hmg. Average counts per pixel 
in the myoeardium were divided by average counts per pixel 
in the lungs to obtain an index of relative antimyosin uptake, 
as previously remxied by our laboratow (19). A hcaVhmg 
ratio of lSSw$uxd to&fen&de n&mal from abttami 
antimyosin studies. 
Ex vim lwgittg dtk admd LtrL A patieitt who under- 
went imaging 48 h after antimyosin injection then underwent 
transplantation II h after the scan. The explanted heact was 










F@ae 1. patient 3. dium-1 I I (“‘ln>labeled mmlonal antimy- 
osin antibody study. A positive tracer uptalc is seen in the antera 
pastedor view. Eleven hours later. the patient underwent hurt 
transplantation. and the excised heart was imaged (see :,g. I). 
sectioned transversely. and up to three slices WCR placed on 
top of the detector. Up to SCWJNI counts were collected. 
&tktial urlysb. Agreewnt between cardicctomy and 
isotopic results was measured with the kappa statistic 
(22.23). The t test was used to compare mutinous variables 
in patients wirh nonnat and abwrmal antimyosin studies. 
Eighteen men and three women, aged 71) to 62 years 
(mean 44 c 13) with a history of heart failure 6 to 145 months 
(mean 51 + 41) before transplantation were included (Table 
I). In two patients a clinical course of <I2 months’ duration 
was noted. The interval between isotopic study and trans. 
plantation was 1 to 90 days (mean 58 i 31): irate patient. 
the interval was ! I h, atrj it was possible to perfom~ bath in 
viva and subsequent ex viva imaging of the excised heart, 
and the time between both studies was 17 h. 
Visual antimyosin uptake was detected in 17 of 21 pa- 
tients. The heatiilungratio at 48 h afterirjection rangedfrorn 
1.20to2.8O(mean I.82 + 0.4O)andwasconsideredabnormal 
in IS (71%) of 21 patients. 
Active mvocwditis was detected in 7 of 21 oatients at 
cardiectomy. In four of these seven patients, the antimyosin 
scans were positive, and in three patients tto uptake was 
detected. Conversely. I I of the 14 patients without myoar- 
ditis at cardiectomy showed positive preoperativa antimy* 
sin ~udies, and in only 3 patients was the scan negative. The 
Ftt 2. A, W~ient 3. Vmtricutar slices of the excised heart EM 6 h 
atkr hean transplantation a d 17 h &er the antimyosin study. B. 
Stices were placed on top ofthc nuclw detector and imaged; tracer 
upt&e is seen in bMh veonicles. 
agreement between cardiectomy and the scans was poor no evidence of active myocarditis was found after examma- 
(kappa = 0.17). tiun of the explanted heart. In addition, only three of seven 
In patient 3, in viva imaging showed moderate preopera- patients wit> eviaence of myG:arditis at cardiectomy 
tive uptake (hearulung ratio 1.89; Fig. 1). He underwent showed antimyosin uptake. In the patient in whom in viva 
transplantation 11 h later, and ex viva myocardial antimyo- and ex viva imaging of the heart was possible, uptake in the 
sin uptake in the three ventricular slices (Fii. 2A) was right and Ieft myocardium was shown, but active myocardi- 
detected 17 h after the in viva imaging. Both the right and the tis was detected in only a small wea of the posterior left 
left ventricle showed global antimyasin uptake (Fig. ZB), but 
active myocarditis was seen at cardiectomy in only a small 
area in the posterior myocardial segment, where ex viva 
uptake was more intense; the remaining myocardium 
showed no signs of myocyte damage. 
Three patients with active myocarditis at explant&m 
had a normal antimyosin study. The mean heart/lung ratia in 
seven patients with myocwditis was 1.62 f 0.24, and the 
ratio in the 14 patients without myocarditis at explant&n 
was 1.92 f 0.43 (p = NS). 
Mean end-diastolic diameter for the entire series was 
79.6 t 15 mm (range 59 to 113): ejection fraction was 24 t 
7% (range 10% to 36%). End-diastolic diameter and ejection 
fraction of the left ventricle were similar in the groups with 
normal and abnormal uptake: 84 f I5 mm versus 78 ? 
IS mm and 25 + 9% versus 23 t 6%, respectively (p = NS). 
Discussion 
In a pwious qort @I), we described the presence of 
ongoing active myocardial damage in patients with chronic 
dilated cardiomyopathy. Antibody uptake in this group did 
not seem to be due to the effects of heart failure because 
patients with a similar degree of disability, left ventricular 
enlargement and systolic dysfunction not due to dilated 
cardiomyopathy did nut show such uptake (21). Therefore, 
there appears to be au intrinsic activity in dilated cardiomy- 
opathy that is not present in other morphologically similar 
forms of heart disease. The question posed is whether 
detection of active myocardial damage by such antibodies in 
these patients reflects the presence of morphologically iden- 
tifiable active myocyte damage or attending infiltration, or 
both. 
The present study is the first clinical comparison between 
monoclonal antimyosin studies performed in patients with 
dilated cardiomyopathy and the ex viva nalysis of the heart. 
ventricular segment; the remaining myocardium showed no 
sians of mvocarditis. In this patient, the wssibility of ex viva 
a&my& uptake due to-early pust&xtem autolysis is 
unlikely because of the positive preoperative isotopic study. 
Therefore, these data suggest hat in dilated cardiomyop- 
athy, antibody uptake cannut b-z equated with the histologic 
presence of myocyte damage and cellular bdiltration, which are 
the patholagic features of active myucarditis (I). 
The significance of such damane detected by antimvwin 
antibali& in the absence of the f&tures of myofyte damage 
or inilammation has yet to be elucidated. Kishimoto et al. 
(24) reported antimyosin uptake in the chronic stage of the 
murine myocarditis model associated with a low ejection 
fraction. but careful pathologic evaluation of the heart re- 
vealed no definitive evidenceof active myacardial necrosis. 
More recently, Bowles et al. (25). using an entemvirus- 
specific complementary deoxyribonucleic acid (cDNA)- 
probe to detect sequences of enterovirus ribonuckic acid 
(RNA), provided evidence of the ~resmce of entercwitus in 
the my&dium of 30% of patients with dilated cardiomy. 
apathy undergoing transplantation: these viruses are defec- 
tive in the control of RNA replication and can persist in the 
myocardium without causing an intlammatmy response, 
either humoral or cellular (26). That such viral persistence 
seems to be clinically relevant is suggested by the recent 
nwrt by Archard et al. (27). who wovide evidence that 
patients in whom virus are detected heave a worse prugnosis 
than those in whom enteroviral persistetxe is not observed, 
the presence af virus being the strongest prognostic predic- 
tor. Whether positive antimyosin studies in patients with 
dilated cardiomyopathy reflect the presence of a persistent 
viral infection is at present uncertain. A collaborative study 
correlating the presence of RNA enterovirtls detected by a 
specific nuclear probe with the presence of monoclonal 
antimyosin antibody uptake is currently underway. 
The interval b&&&antimyusin imaging -ad cardiac ex- 
plantation was reasonably short, 58 days. Although it could 
we are gmM”l loGPiet* Ftrmsnyrr. MD. RD sa LPOMd C. Archafd, of 
the Chting Crms and Wertminwr Medical School. Ior thdr helplul criti. 
be ressoned that histopathologic hanges might still develop cim, and 10 Jnune Mmgat for wtirtkd advice and Came CasMovaa for 
during this period (e.g., acute myocarditis at the time of relrlsrisl work. 
imaging resolved at the moment of explantation). this is 
unlikely because the patients involved iad chronic dilated 
cardiomyopathy (mean interval between onset of symptoms References 
and transplantation was 51 months) and therefore a low 
sensitivity in detection of active myocarditis would be ex- 
petted in this group. 
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